Zimmer Biomet issues $1.75B in notes at 4.700%, 5.050%, and 5.500%

ZIMMER BIOMET HOLDINGS, INC.

Offering includes $600M 4.700% notes due 2027, $550M 5.050% notes due 2030, and $600M 5.500% notes due 2035.
Interest payable semi-annually; closing expected February 19, 2025 subject to customary conditions.
Net proceeds to redeem a portion of the outstanding 3.550% notes due 2025 and for general corporate purposes.
Underwriters include Goldman Sachs, Barclays, Citi, Morgan Stanley, and SMBC Nikko.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.